E. Feldman
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 15
- Acute Myeloid Leukemia Research 13
- Chronic Myeloid Leukemia Treatments 5
- Multiple Myeloma Research and Treatments 3
- Oncology 7
- Co-authors
- Karen Seiter (3 shared papers)P. Maslak (1 shared paper)Toby Gee (1 shared paper)David A. Scheinberg (1 shared paper)Joseph Bertino (1 shared paper)Ellin Berman (1 shared paper)David W. Golde (1 shared paper)Peter L. Greenberg (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer (1 paper)Acta Haematologica (1 paper)British Journal of Haematology (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
E. Feldman
18 papers receiving 161 citations
Peers
Comparison fields: 5 of 28
- Hematology 120
- Genetics 48
- Public Health, Environmental and Occupational Health 65
- Oncology 51
- Pathology and Forensic Medicine 24
Countries citing papers authored by E. Feldman
This map shows the geographic impact of E. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Feldman more than expected).
Fields of papers citing papers by E. Feldman
This network shows the impact of papers produced by E. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Feldman. The network helps show where E. Feldman may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 48 | |
| 2 | 2005 | 29 | |
| 3 | High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. | 1989 | 25 |
| 4 | 2000 | 15 | |
| 5 | 1999 | 9 | |
| 6 | 2010 | 6 | |
| 7 | 2011 | 5 | |
| 8 | 2011 | 5 | |
| 9 | Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas. | 1994 | 4 |
| 10 | 2005 | 4 | |
| 11 | 2005 | 3 | |
| 12 | 2010 | 3 | |
| 13 | 1989 | 2 | |
| 14 | 1999 | 2 | |
| 15 | 2011 | 2 | |
| 16 | 1990 | 1 | |
| 17 | 1992 | 1 | |
| 18 | 2005 | 1 | |
| 19 | 2024 | 0 |
About E. Feldman
E. Feldman is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Organic Chemistry, having authored 19 papers that have together received 165 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (5 papers), Histone Deacetylase Inhibitors Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hematology (120 citations), Genetics (48 citations), Public Health, Environmental and Occupational Health (65 citations), Oncology (51 citations) and Pathology and Forensic Medicine (24 citations). E. Feldman has collaborated with scholars based in United States and India. Frequent co-authors include Karen Seiter, P. Maslak, Toby Gee, David A. Scheinberg, Joseph Bertino, Ellin Berman, David W. Golde, Peter L. Greenberg, Azra Raza and Jerome B. Zeldis. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Acta Haematologica, British Journal of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.